@article{87ca324291b64c2998d901b8da612f46,
title = "Safety of Early Discontinuation of Antiseizure Medication after Acute Symptomatic Neonatal Seizures - Reply",
author = "Glass, {Hannah C.} and Shellhaas, {Ren{\'e}e A.}",
note = "Funding Information: Dr Haas reported personal fees from Sun Pharmaceuticals outside the submitted work. Dr Glass has received payment for legal consulting. Dr Shellhaas serves as associate editor for Neurology, receives royalties from UpToDate for authorship of topics on neonatal seizures, and is a consultant for the Epilepsy Study Consortium. The Patient-Centered Outcomes Research Institute supported the Original Investigation (grant 2015C2-1507-31187). Funding Information: Conflict of Interest Disclosures: Dr Haas reported personal fees from Sun Pharmaceuticals outside the submitted work. Dr Glass has received payment for legal consulting. Dr Shellhaas serves as associate editor for Neurology, receives royalties from UpToDate for authorship of topics on neonatal seizures, and is a consultant for the Epilepsy Study Consortium. The Patient-Centered Outcomes Research Institute supported the Original Investigation (grant 2015C2-1507-31187).",
year = "2022",
doi = "10.1001/jamaneurol.2021.4112",
language = "English",
volume = "79",
pages = "91--92",
journal = "JAMA Neurology",
issn = "2168-6149",
number = "1",
}